Early Career Psychiatrists

Recently published articles about Early Career Psychiatrists

JCP
Zuranolone for Postpartum Depression in Real-World Clinical Practice
Case Report

July 2, 2025

Three cases of successful treatment of postpartum depression with zuranolone are presented and discussed.
,
JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al
JCP
Estimating the 12-Hour Serum Lithium Level
Original Research

March 3, 2025

Lithium blood tests should be conducted 12 hours after the last lithium dose, but complying with this strict timing is difficult. The authors developed a simple tool to estimate...
, , , et al
Weekly Mind Reader: Teaching Doctors in a Pandemic
news

February 14, 2025

This week, we share something good that came out of the pandemic, take a dive into target trial emulation, and look at a cannabis case study.
JCP
ECT for Psychotic vs Nonpsychotic Depression
Original Research

January 29, 2025

Patients with major depression with psychotic features had higher response rates to ECT than those without psychotic features and similar rates of adverse cognitive effects. After adjustment for confounders,...
, , , et al
JCP
Sulforaphane Added to Antipsychotics for Negative Symptoms of Schizophrenia
Original Research

January 20, 2025

Add-on high dose sulforaphane may reduce negative symptoms in patients with schizophrenia, although the clinical significance of this reduction needs further evaluation.
, , , et al

Recent JCP Articles on Early Career Psychiatrists

JCP
IV Hydroxyzine vs Haloperidol for Delirium
Original Research

January 6, 2025

Hydroxyzine showed a significantly higher rate of delirium improvement than haloperidol, with no significant difference in the time to improvement.
, , , et al
JCP
Substance and Opioid Use Disorders Among IBD Hospitalizations
Original Research

January 2, 2025

A higher prevalence of SUD and opioid use disorder was found among hospitalizations for inflammatory bowel disease, and these elevated prevalences were linked to distinct demographic, socioeconomic, and geographic...
, , , et al
JCP
Sex Differences in Antidepressant Acceptability
Original Research

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of...
, , , et al

Featured Early Career Psychiatrists Research

JCP
Opioid Use Disorder Treatment in Sexually and Gender Diverse Patients
Original Research

October 30, 2024

The disparities in buprenorphine prescriptions and in outpatient medical visit access between sexually and gender diverse (SGD) and non-SGD cohorts found in this study highlight priorities for culturally responsive...
, , , et al
JCP
Bridge Symptoms Between Borderline Personality and PTSD
Original Research

September 9, 2024

Self-aggression, feelings of emptiness, dissociation, and feelings of detachment were found to be bridge symptoms between borderline personality disorder and PTSD. Targeting these might allow better prevention and management...
, , , et al
JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
, , , et al

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe